KOSDAQ large cap
L&C BIO
A regenerative-medicine firm developing human-tissue grafts, supplying skin and cartilage implants and biomaterials for tissue repair. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
290650.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'21-12.7%'22-30.2%'23+7.9%'24-2.5%'25+301.2%YTD-21.1%
Money in ▸·
L&C BIO
▸ Money out·
Financials & Segments
- Segments · Human-tissue grafts · Biomaterials
Revenue from
No refined links yet.
Pays to
No refined links yet.